跳转至内容
Merck
CN

K1751

酮洛芬

≥98% (TLC), powder, non-steroidal anti-inflammatory compound

别名:

2-(3-苯甲酰苯基)丙酸

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C16H14O3
化学文摘社编号:
22071-15-4
分子量:
254.28
NACRES:
NA.77
PubChem Substance ID:
57654315
UNSPSC Code:
12352200
EC Number:
244-759-8
MDL number:
MFCD00055790

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

酮洛芬, ≥98% (TLC)

InChI key

DKYWVDODHFEZIM-UHFFFAOYSA-N

InChI

1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)

SMILES string

CC(C(O)=O)c1cccc(c1)C(=O)c2ccccc2

biological source

synthetic

assay

≥98% (TLC)

form

powder

solubility

ethanol: 50 mg/mL, clear, colorless to yellow

originator

Bayer

Quality Level

200

Gene Information

human ... ALB(213), IL8RA(3577), PTGS1(5742), PTGS2(5743)

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

酮洛芬已被用于：
  • 作为检测样品，通过色谱和显微技术分析长储存期的影响
  • 作为非选择性COX抑制剂，在大鼠皮下注射，研究其对应激/盐酸甲基苯丙胺诱导的闭合蛋白、紧密连接蛋白-5和COX-2蛋白免疫反应性、β-营养不良聚糖的截短、脑水含量、以及异硫氰酸荧光素-葡聚糖外渗的变化的影响
  • 在磷酸盐缓冲液中研究其抑制热诱导白蛋白变性的能力

Biochem/physiol Actions

它可作为治疗强直性脊柱炎、类风湿性关节炎和骨关节炎的有效药物。 它还具有解热和镇痛作用。酮洛芬可防止前列腺素合成酶的作用。
非甾体类抗炎化合物，具有COX-1选择性。

Features and Benefits

该化合物由Bayer开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。

General description

酮洛芬属于2-芳基丙酸类化合物。

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Eye Irrit. 2 - Skin Irrit. 2

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
WXBF2607V
BCCK2800
BCCJ8530
BCCH4038
BCCD0399

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ekaterina Blinova et al.
International journal of molecular sciences, 22(18) (2021-09-29)
The possible involvement of p53 signaling, FGFR3 expression, and FGFR3 mutation rates in the prediction of the NMIBC anti-PD-L1 treatment response needs to be clarified. The main aim of our study was to explore predictive value of p53 expression, FGFR3
Polyamidoamine dendrimers used as solubility enhancers of ketoprofen
Yiyun C, et al.
European Journal of Medicinal Chemistry, 40(12), 1390-1393 (2005)
Ekaterina Blinova et al.
Biomolecules, 11(6) (2021-07-03)
The main goal of our study was to explore the wound-healing property of a novel cerium-containing N-acethyl-6-aminohexanoate acid compound and determine key molecular targets of the compound mode of action in diabetic animals. Cerium N-acetyl-6-aminohexanoate (laboratory name LHT-8-17) as a
In vitro chiral conversion, phase separation, and wave propagation in aged profen solutions
Sajewicz M, et al.
Journal of Liquid Chromatography and Related Technologies, 32(9), 1359-1372 (2009)
Elisabeth Christiansen et al.
Journal of medicinal chemistry, 54(19), 6691-6703 (2011-08-23)
The free fatty acid receptor 1 (FFA1, also known as GPR40) enhances glucose-stimulated insulin secretion from pancreatic β-cells and is recognized as an interesting new target for treatment of type 2 diabetes. Several series of selective FFA1 agonists are already
查看所有相关文献

商品

Discover Bioactive Small Molecules for Lipid Signaling Research

Discover Bioactive Small Molecules for Lipid Signaling Research

Using Human iPS Cell-derived Colon Organoids for Cytotoxicity Screening of Drug Compounds

Human epithelial intestinal colonic organoids can be used as an alternative to Caco-2 drug permeability assays for drug screening and compound toxicity testing.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持